Versor Investments LP Sells 2,356 Shares of Axon Enterprise, Inc $AXON

Versor Investments LP decreased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 84.2% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 442 shares of the biotechnology company’s stock after selling 2,356 shares during the quarter. Versor Investments LP’s holdings in Axon Enterprise were worth $366,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of AXON. TCTC Holdings LLC raised its stake in Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after buying an additional 24 shares during the period. Banque Transatlantique SA bought a new stake in Axon Enterprise in the first quarter valued at approximately $31,000. Flaharty Asset Management LLC bought a new stake in Axon Enterprise in the first quarter valued at approximately $33,000. Hemington Wealth Management raised its stake in Axon Enterprise by 70.8% in the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 17 shares during the period. Finally, Whipplewood Advisors LLC raised its stake in Axon Enterprise by 192.9% in the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after buying an additional 27 shares during the period. Institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on AXON. JMP Securities restated a “market outperform” rating and issued a $825.00 price objective on shares of Axon Enterprise in a research note on Monday, September 29th. Bank of America upped their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research report on Thursday, July 17th. Needham & Company LLC reaffirmed a “buy” rating and issued a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. Finally, Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. Fifteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $813.07.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $713.74, for a total value of $7,137,400.00. Following the sale, the chief executive officer owned 3,033,982 shares of the company’s stock, valued at approximately $2,165,474,312.68. This trade represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares in the company, valued at approximately $11,402,280. This represents a 0.51% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 59,932 shares of company stock worth $45,115,616. 4.40% of the stock is owned by insiders.

Axon Enterprise Trading Down 9.4%

Shares of NASDAQ:AXON opened at $639.53 on Thursday. The business’s 50 day simple moving average is $726.40 and its 200 day simple moving average is $735.39. The company has a market capitalization of $50.21 billion, a P/E ratio of 157.91, a P/E/G ratio of 29.49 and a beta of 1.41. Axon Enterprise, Inc has a 1 year low of $450.72 and a 1 year high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, November 4th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The business had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company’s revenue for the quarter was up 30.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.45 EPS. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.